-
1
المؤلفون: Lucia De Prado Gomez, PharmD, MSc, Asif H. Khan, MBBS, MPH, Anju T. Peters, MD, Claus Bachert, MD, PhD, Martin Wagenmann, MD, Enrico Heffler, MD, PhD, Claire Hopkins, BMBCh, Peter W. Hellings, MD, PhD, Mei Zhang, PhD, Jun Xing, PhD, Paul Rowe, MD, Juby A. Jacob-Nara, MD, MPH, DHSc
المساهمون: Ear, Nose and Throat
المصدر: American journal of rhinology & allergy, 36(6), 788-795. OceanSide Publications Inc.
مصطلحات موضوعية: Adult, Biological Products, Interleukin-13, CRSwNP, General Medicine, Immunoglobulin E, Antibodies, Monoclonal, Humanized, EVEREST trial, chronic rhinosinusitis with nasal polyps, Asthma, Nasal Polyps, study design, Otorhinolaryngology, dupilumab, Chronic Disease, phase 4, type 2 inflammatory, Humans, omalizumab, Immunology and Allergy, biologics, Sinusitis, Rhinitis
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb06d15972d690ea2d7dc9e235151396
https://doi.org/10.1177/19458924221112211